Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04126681 |
| Consolidated Lead Sponsor | Ascentage Pharma Group |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 144 participants (ACTUAL) |
| Registered Start Date | 2019-10-21 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University People's Hospital | Beijing, China | Open Hospital Dossier -> |
| Sun Yat-sen University Cancer Center | Guangzhou, China | Open Hospital Dossier -> |
| Nanfang Hospital of Southern Medical University | Guangzhou, China | Open Hospital Dossier -> |
| Shenzhen Second People's Hospital | Shenzhen, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.